Back to Journals » OncoTargets and Therapy » Volume 17
Case report
MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
1,042 | Dovepress* | 1,042+ | 27 | 1,069 | |
Totals | 1,042 | 27 | 1,069 | ||
*Since 9 April 2024 |
View citations on PubMed Central and Google Scholar